Form 8-K - Current report:
SEC Accession No. 0000950170-25-064624
Filing Date
2025-05-06
Accepted
2025-05-06 17:15:17
Documents
11
Period of Report
2025-05-01
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rani-20250501.htm   iXBRL 8-K 47078
  Complete submission text file 0000950170-25-064624.txt   165268

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rani-20250501.xsd EX-101.SCH 26034
13 EXTRACTED XBRL INSTANCE DOCUMENT rani-20250501_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 25918313
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)